US Patent Issued to ADLAI NORTYE BIOPHARMA on May 12 for "High-activity Wnt pathway inhibitor compound" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,917, issued on May 12, was assigned to ADLAI NORTYE BIOPHARMA Co. LTD. (Hangzhou, China).

"High-activity Wnt pathway inhibitor compound" was invented by Yufeng Chen (Hangzhou, China), Peng Wu (Hangzhou, China), Meng Lv (Hangzhou, China), Canfeng Liu (Hangzhou, China), Han Yang (Hangzhou, China), Kaixuan Chen (Hangzhou, China), Wanli Cheng (Hangzhou, China), Feifan Li (Hangzhou, China), Youping Wang (Hangzhou, China), Keke Chen (Hangzhou, China), Pingping Lu (Hangzhou, China) and Nanhai He (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a compound having the structure of formula (I) for inhibiting Wnt pathway activity, a p...